AVS3

Blue Bell, United States Founded: 1998 • Age: 28 yrs Acquired By Altura Capital
Provider of process control, training batch certification services for medical devices manufacturers

About AVS3

AVS3 is a company based in Blue Bell (United States) founded in 1998 was acquired by Altura Capital in May 2022.. AVS3 offers products and services including Validation Services, Regulatory Compliance Consulting, and Automation Solutions. AVS3 operates in a competitive market with competitors including AlphaLab Health, cGMP Validation, Wickham Laboratories, Rubizon and Sublime Stericeuticals, among others.

  • Headquarter Blue Bell, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Altura Capital

    (May 16, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AVS3

AVS3 offers a comprehensive portfolio of products and services, including Validation Services, Regulatory Compliance Consulting, and Automation Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Offers validation for pharmaceutical processes and systems worldwide

Provides guidance on regulatory strategies and submissions for clients

Delivers automation for quality and compliance in life sciences industries

People of AVS3
Headcount 50-200
Employee Profiles 5
Employee Profiles
People
Ruben Dario Taborda
Chief Executive Officer
People
Arleen Candari
Vice President Of Business Development
People
Denise Painter
HR & Operations Manager

Unlock access to complete

Funding Insights of AVS3

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Private Equity Round - AVS3 Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AVS3

AVS3 has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Altura Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Altura Capital is recognized as a business enabler and investment platform.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AVS3

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AVS3

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Avs3 Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AVS3

AVS3 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AlphaLab Health, cGMP Validation, Wickham Laboratories, Rubizon and Sublime Stericeuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Market research for pharmaceuticals is provided by AlphaLab Health.
domain founded_year HQ Location
Offers validation, compliance, and consulting services for life sciences sectors.
domain founded_year HQ Location
Provider of medical device & pharmaceutical product testing services
domain founded_year HQ Location
Provider of clinical process development, verification, analytical, quality management and regulatory services
domain founded_year HQ Location
Develops continuous lyophilization processes for stabilizing injectable medicines and vaccines.
domain founded_year HQ Location
Manufacturing validation services are provided for the biopharma sector.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Avs3

Frequently Asked Questions about AVS3

When was AVS3 founded?

AVS3 was founded in 1998 and raised its 1st funding round 24 years after it was founded.

Where is AVS3 located?

AVS3 is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.

What does AVS3 do?

AVS was founded in 1998 and is headquartered in Blue Bell, United States. Operations are centered on the medical devices sector, where process control, training, and batch certification services are delivered to manufacturers. These services support quality assurance and regulatory compliance in production environments. The company maintains a focus on specialized assistance for device fabrication processes across the United States.

Who are the top competitors of AVS3?

AVS3's top competitors include AlphaLab Health, Rubizon and Wickham Laboratories.

What products or services does AVS3 offer?

AVS3 offers Validation Services, Regulatory Compliance Consulting, and Automation Solutions.

Who are AVS3's investors?

AVS3 has 1 investor. Key investors include Altura Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available